Sam Glick will be
EVP for Enterprise Strategy and Business Development; Shelby Decosta will be chief business
development officer.
OAKLAND,
Calif., April 29, 2024 /PRNewswire/ -- Sam
Glick will join Kaiser Permanente as executive vice president for
enterprise strategy and business development. He will be
responsible for enterprisewide strategy and business development.
He will oversee the strategy, business development, government
relations, communications, innovation and enterprise risk
management functions as well as Kaiser Permanente Ventures and
Kaiser Permanente International programs. In this role, Glick will
develop and connect strategies across the organization's entire
portfolio of businesses including Kaiser Permanente's integrated
care and coverage, Risant Health, the KP Medical Foundation, the
National Health Plan, and future new businesses.
Glick's service will begin in June
2024 when he replaces Paul
Swenson, executive vice president and chief administrative
officer, who has announced he will be stepping down from the role
after leading the organization's strategy for more than a decade.
While stepping down from the role, Swenson will continue with the
organization for a period of time to work on special projects.
Glick will report to Kaiser Permanente's chair and chief executive
officer, Greg A. Adams.
Glick joins Kaiser Permanente from Oliver Wyman, an
international management consulting firm, where he has served as
global leader of health and life sciences, working with health
systems, health plans, and other health care organizations across
the country to be more responsive to market and consumer needs. He
also currently leads the firm's global marketing function and
serves as a member of the Oliver Wyman Global Leadership Team and
the Marsh McLennan Senior Leadership Team. Prior to his roles at
Oliver Wyman, Glick helped to build the strategy and corporate
development function at Mercer, the country's largest employee
benefits broker and consultant.
"Sam's broad understanding of the health care marketplace,
collaborative relationships with industry leaders, and broad
leadership experience will help us as we strengthen our enterprise
strategy and business development capabilities," said Adams. "His
leadership will help us as we continue to respond to the external
market and address the challenges that we and all of health care
currently face."
Shelby Decosta has been named
Kaiser Permanente's new chief business development officer with
overall responsibility and accountability for growing Kaiser
Permanente's mission and touching more lives through mergers,
acquisitions, market expansion and service line diversification for
Kaiser Permanente, Risant Health, and other businesses. She will
serve on the executive teams for Kaiser Permanente and Risant
Health and work closely with senior leaders across the
enterprise.
Decosta joins Kaiser Permanente from UCSF Health where she
currently serves as president for UCSF Health care network and
chief market development officer, responsible for mergers,
acquisitions and strategic partnerships. She also manages UCSF
Health's accountable care organization, joint ventures and
management agreements with community health systems, as well as the
system's ambulatory outpatient centers and physician
network. Prior to UCSF Health, Decosta held leadership
positions at Trinity Health and Dignity Health with accountability
for mergers, acquisitions and partnerships.
"Shelby's collaborative, innovative, results-driven approach, as
well as her experience establishing and implementing diversified
growth initiatives across community and academic nonprofit health
systems, will help Kaiser Permanente continue to grow our
enterprise," said Adams.
Decosta will begin her service in July
2024 and report to Glick.
Contact:
Hilary Costa
Hilary.C.Costa@kp.org
View original content to download
multimedia:https://www.prnewswire.com/news-releases/kaiser-permanente-names-new-enterprise-strategy-business-development-leadership-302130432.html
SOURCE Kaiser Permanente